- Home
- JUNS vs DRCT Comparison
JUNS vs DRCT Comparison
Compare JUNS & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JUNS
- DRCT
- Stock Information
- Founded
- JUNS 2015
- DRCT 2018
- Country
- JUNS United States
- DRCT United States
- Employees
- JUNS N/A
- DRCT N/A
- Industry
- JUNS
- DRCT Computer Software: Programming Data Processing
- Sector
- JUNS
- DRCT Technology
- Exchange
- JUNS NYSE
- DRCT Nasdaq
- Market Cap
- JUNS 20.5M
- DRCT 16.7M
- IPO Year
- JUNS 2024
- DRCT 2022
- Fundamental
- Price
- JUNS $2.78
- DRCT $0.55
- Analyst Decision
- JUNS
- DRCT Strong Buy
- Analyst Count
- JUNS 0
- DRCT 1
- Target Price
- JUNS N/A
- DRCT $6.00
- AVG Volume (30 Days)
- JUNS 680.7K
- DRCT 157.5K
- Earning Date
- JUNS 08-11-2025
- DRCT 05-06-2025
- Dividend Yield
- JUNS N/A
- DRCT N/A
- EPS Growth
- JUNS N/A
- DRCT N/A
- EPS
- JUNS N/A
- DRCT N/A
- Revenue
- JUNS N/A
- DRCT $48,170,000.00
- Revenue This Year
- JUNS N/A
- DRCT $50.71
- Revenue Next Year
- JUNS N/A
- DRCT $26.31
- P/E Ratio
- JUNS N/A
- DRCT N/A
- Revenue Growth
- JUNS N/A
- DRCT N/A
- 52 Week Low
- JUNS $0.51
- DRCT $0.44
- 52 Week High
- JUNS $19.51
- DRCT $6.59
- Technical
- Relative Strength Index (RSI)
- JUNS N/A
- DRCT 55.55
- Support Level
- JUNS N/A
- DRCT $0.56
- Resistance Level
- JUNS N/A
- DRCT $0.68
- Average True Range (ATR)
- JUNS 0.00
- DRCT 0.04
- MACD
- JUNS 0.00
- DRCT 0.01
- Stochastic Oscillator
- JUNS 0.00
- DRCT 49.94
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.